Back to Selection     Print       Date : 30 Sep 2026
Fund Summary
Aditya Birla SL Quant Fund Reg (G)
[Equity: Thematic]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-24
Corpus(Cr.) 1855.00 Latest NAV 9.61 As on 29-10-2026
Equity(%) 99.84 52 Week High 10.48
Debt(%) 0.16 52 Week Low 8.9
Others(%) 0.00 Exit Load 0.5% for redemption within 90 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 0.00
Scheme Benchmark NIFTY 200 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Harish Krishnan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The Scheme seeks to generate long term capital appreciation by investing in equity and equity related securities based on quant model theme. The Scheme does not guarantee/indicate any returns. There is no assurance that the investment objective of the Scheme will be achieved.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 21.76%
Top 10 Holdings 39.89%
Top 25 Holdings 75.54%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 19.64
Automobile 12.62
Industrial Products 10.99
Food Beverage & Tobacco 8.62
Healthcare 6.63
Metals 5.97
Chemicals 5.63
Finance & Investments 5.5
Banking & Financial 5.16
Construction 5.01
Agricultural & Farm Machinery 4.76
Ferrous Metals 3.14
Software & Services 1.87
Retail 1.44
Transportation 1.23
Electricals 0.87
Minerals & Mining 0.76
Cash 0.16
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.71
PE Ratio 31.59
 
Top 25 Holdings
Holdings Net Asset(%)
Marico Limited 4.76
Torrent Pharmaceuticals Ltd. 4.55
Apollo Hospitals Enterprises Ltd. 4.29
Nestle India Ltd. 4.13
Grasim Industries Ltd 4.03
Laurus Labs Limited 4.03
Federal Bank Ltd. 3.98
Sun Pharmaceutical Industries Ltd. 3.55
Hindalco Industries Ltd. 3.54
Glenmark Pharmaceuticals ltd 3.03
APL Apollo Tubes Limited 2.79
Eicher Motors Ltd. 2.78
Cummins India Ltd. 2.50
Navin Fluorine International Limited 2.48
Polycab India Limited 2.46
Vedanta Ltd. 2.43
Divis Laboratories Ltd. 2.36
L&T Finance Limited 2.35
Radico Khaitan Ltd. 2.35
Aster DM Healthcare Limited 2.34
Pidilite Industries Ltd. 2.32
AIA Engineering Ltd. 2.14
United Spirits Limited 2.14
Zydus Lifesciences Limited 2.12
Bharat Forge Ltd 2.09

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-1.84% -5.97% -2.04% -2.83%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.01% -5.23% -4.33% -11.05%
 
Scheme Benchmark [NSE - Nifty 200 TRI]
-0.12% -5.86% -4.03% -8.38%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
-0.67% 0.00% 0.00% 0.00%
 
 
-2.07% 7.60% 6.59% 11.58%
 
 
-1.09% 10.07% 8.25% 12.21%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Aditya Birla SL Quant Fund Reg (G) 0.00% 0.0000 0.0000% 0.0000 0.0000
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Aditya Birla SL Quant Fund Reg (G) 0.0000% 0.0000 0.0000 0.0000 0.0000
 
Back to Selection